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Despite numerous theories, the etiology and patho-
genesis of primary varicose veins remain unclear. The 
etiology of chronic venous diseases (CVDs) known as 
chronic venous insufficiency (CVI) is related to leuko-
cyte trapping. Leukocyte trapping involves trapping 
of white cells in vessel walls followed by their acti-
vation and translocation outside the vessel. Release 
of reactive oxygen species (ROS) from trapped white 
cells has been documented. Superoxide dismutase 
(SOD) directly inhibits the generation of free radicals 
and compounds that are produced during oxidation 
by ROS, such as malonyldialdehyde (MDA). The aim of 
this study was to determine the involvement of free 
radicals in the etiology of venous changes. The follow-
ing material was used for the study: fragments of suf-
ficient or insufficient venous system and varices from 
31 patients diagnosed with chronic venous disease in 
the 2nd or 3rd degree, according to clinical state, eti-
ology, anatomy and pathophysiology (CEAP), which 
were qualified for surgical procedure. The levels of ox-
idative stress markers strongly correlated with lesions 
observed by USG in insufficient and varicose veins. In 
both a higher concentration of MDA was observed, 
which is a sign of lipid peroxidation. Antioxidative 
mechanisms, SOD activity and total antioxidative pow-
er expressed as FRAP were inversely proportional to 
MDA concentration. In insufficient and varicose veins 
both FRAP and SOD activities were significantly lower 
than in normal veins. The severity of clinical changes 
was  inversely dependent on the efficiency of scav-
enging of ROS, which additionally proves the partici-
pation of free radicals in pathogenesis of CVDs.
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InTRODUCTIOn
In Western Europe, varicose veins are included in 
the most frequently occurring syndromes in women and 
men, 65 % and 50 %, respectively. Varices are placed 
second in relation to the prevalence of CVI syndromes 
concerning women and men, 25–33 % and 10–20 %, re-
spectively (e.g., Slagsvold et al., 2009; Egyetem & Orvos-
tudomanyi, 2010). 
Nevertheless, the etiology of varicose veins remains 
unclear. Some probable factors leading to the develop-
ment of VVs have been reported. One such factor is 
dysfunction of vascular endothelium, which could be a 
result of excessive generation of reactive oxygen species 
(ROS), depletion of antioxidant defense and oxidative 
stress development (Yasim et al., 2008). Among other 
factors, inflammatory processes (Bergan et al., 2008) and 
release of proinflammatory cytokines have been men-
tioned (Fig. 1) (Mangiafico et al., 1997).
Under physiological conditions, generation of ROS 
in the cell is controlled by antioxidant defense enzymes. 
Most important amongst these are superoxide dismutase 
(SOD), which catalyze the dismutation of superoxide to 
hydrogen peroxide, and catalase (CAT), which together 
with glutathione peroxidase (GPx) converts hydrogen 
peroxides to water and oxygen (Halliwell & Gutteridge, 
2000). In the case of depletion or inactivation of these 
enzymes overproduction of superoxide anions, hydroxyl 
radicals or hydrogen peroxide occurs. These ROS may 
lead to the destruction of lipid membranes, proteins and 
other molecules in the endothelium. In turn, ROS stimu-
late the release of proinflammatory cytokines from dam-
aged endothelial cells. These destructive effects may be 
attenuated by leukocytes that are trapped and activated 
in the venous walls.
The etiology of chronic venous disease (CVD), also 
known as CVI, is related to leukocyte trapping. Leuko-
cyte trapping consist of trapping of white cells in vessel 
walls, their activation and translocation outside the ves-
sel, resulting in increased blood viscosity and elevated 
blood flow resistance. These symptoms are manifested 
by increased endothelial permeability and escape of flu-
ids, circumvascular edema and capillary stenosis (Valen-
cia et al., 2001).
Many authors have studied the influence of anoxia 
(resulting from blood stagnation) on the interactions 
between the epithelium and multinuclear macrophages, 
monocytes, and neutrophils during saphenous vein per-
fusion (Matić  et al., 2000). Those studies showed the 
adhesion of multinuclear cells to anoxic epithelium of 
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varices and insufficient veins is much stronger than for 
sufficient fragments. This phenomenon may be respon-
sible for the activation of multinuclear cells with angi-
otensin II, which may later activate NAD(P)H oxidase 
and potentiate the production of superoxide anion radi-
cals (Fig. 1) (Heistad, 2006). These radicals oxidize lipids 
and, therefore, lead to the depletion of both enzymatic 
and non-enzymatic antioxidant mechanisms (Cordis et al., 
1998). 
Formation of O.–2 and H2O2 by xanthine oxidase (XO) 
increased during reperfusion after hypoxia in cardiovas-
cular disease. Development of CVI involves many dif-
ferent stages. Organic peroxides and H2O2 are promoters 
of inflammation process of diseases with pro-inflamma-
tory character. It was observed that chronic inflamma-
tion could be conducive in the process of carcinogenesis. 
It was shown that induced granulocytes could damage 
DNA of neighboring cells. This occurred during inflam-
mation process in various diseases, when phagocytes re-
lease ROS not only to phagosomes but also outside the 
cell. Part of ROS attack foreign objects, against which 
they are formed; however, remaining ROS are flowing in 
extracellular fluids where they encounter other cells. In 
sites, where local inflammatory process is occurring on 
and many stimulated phagocytes are accumulated, con-
centrations of released ROS may be high. The inflam-
matory reaction has a mechanism of  positive feedback; 
exposure of plasma to action of activated phagocytes re-
sults in generation of chemotactic factors and activating 
new lymphocytes (Madamanchi et al., 2005). Generation 
of chemotactic factors is inhibited by SOD. It might 
mean that the factor responsible for SOD generation 
is O.–2 (Cooke et al., 2003). Another element of positive 
feedback during CVI development might be the induc-
tion of thrombocytes aggregation by anion radical su-
peroxide and hydrogen peroxide, which in consequence 
might result in microthrombus formation. A situation is 
possible, when ROS released in a site of accumulation 
of huge number of activated phagocytes will damage 
surrounding tissues by exposing them to strong oxida-
tive stress and enzymes. During the course of CVI, an 
increase in the level of hemosiderin related to iron me-
tabolism is observed. Hemosiderin at physiological con-
centration protects from ROS. In addition, it captures 
hemoglobin and hem released from damaged erythro-
cytes, and inhibits release of Fe ions that can later cata-
lyze Haber-Weiss reaction:
       Fe2+/Fe3+
O2
– + H2O2 → OH• + OH
− + O2
In Haber-Weiss reaction, in the presence of free iron 
ions, with the participation of reactive biologically par-
tially reduced oxygen forms (O2
– and H2O2), an OH• 
free radical is formed, which can react with every bio-
logical molecule being in its direct neighborhood. 
Fe2+ + H2O2 → Fe
3+ + OH− + OH•
Fe3+ + O2
– → Fe2+ + O2
This OH• radical may initiate separation of hydrogen 
atom from polyunsaturated fatty acids (LH) or result in 
peroxidation of lipids of cell membranes, whose oxida-
tive forms are strongly cytotoxic. 
OH• + LH → H2O + L
o
Lo  + LH → LOOo
LOOo + LH → LOOH + Lo
Lipid hydroperoxides (LOOH) are accumulated, and 
in the presence of free iron ions they can initiate addi-
tional lipid peroxidation. 
Fe2+ + LOOH → Fe3+ + LO o + OH−
LO o + LH → LOH + Lo
These reactions have a cascade mechanism. The OH• 
radical is strictly reactive, its cytotoxic effect also con-
cerns DNA molecules, causing breaks in DNA strands 
(forming 8-hydroxy-2΄-deoxyguanosine) (Oliński & Jur-
gowiak, 2002). 
In case of CVI, a relationship can be noticed be-
tween the level of oxidative DNA damages and the 
level of iron ions localized in the tissues. Such obser-
vations were made by Jabłońska and Krzyściak (2010), 
where they noticed increased level of Fe concentration 
in varicose veins in comparison to sufficient vessels, 
30.9 % and 197.16 %, respectively. In these studies, av-
erage concentration of iron significantly increased in 
insufficient venous vessels (from 54.4 (± 43.9) to 64.8) 
and varicose veins (from 70.7 (± 46.9) to 90.1). These 
observations can be explained by the function, which 
is played by iron in CVI condition. This increase was 
significantly correlated with oxidative DNA damages 
of blood lymphocytes of CVI patients, which was ob-
served by Krzyściak et al. (2010). This can be explained 
by growing concentration of free iron catalyses changes 
during Haber-Weiss reaction, in which OH• is formed. 
Huge amount of hydroxyl radical results in disorders of 
tissue functions, cells damage, destruction of proteins, 
lipids, carbohydrates as well as DNA. It has influence 
on oxidative stress, being one of the causes of CVI.
ThE AIM OF ThE STUDy
The aim of the study was to establish the role of free 
radicals participation in the etiology of vein dysfunction. 
The study was made to verify hypothesis that one frag-
ment of ischemic, damaged vein can induce further le-
sions in competent fragment of the same vein. 
Figure 1. Mechanisms that may contribute to varicose vein for-
mation
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MATERIAL
The material used for the study comprised fragments 
of sufficient or insufficient venous system and varices 
from 31 patients (23 women and 8 men aged 26 to 68 
years, mean age 49.9 years ± 12.5 S.D.) with diagnosed 
chronic venous disease of the 2nd or 3rd degree, accord-
ing to the clinical state, etiology, anatomy and patho-
physiology (CEAP), which were qualified to undergo 
surgical procedure.
All participants underwent a medical interview, physi-
cal examinations, and duplex sonography. The symptoms 
of chronic venous disease had been observed for more 
than one year in all patients. Biochemical examinations, 
morphology, coagulation parameters were performed in 
all patients before the surgical procedure (Table 1).
Consents were obtained from all patients, and the 
study procedure was approved by the Bioethical Commit-
tee of the Jagiellonian University (KBET/125/B/2007).
During the operation, entire trunk of the great saphe-
nous vein (GSV) (from ankle to groin) was extracted. 
The part located near medial ankle was considered suf-
ficient in ultrasonographical (USG) examination. Extrac-
tion of this part had to be made because of varicose 
veins and perforator localization. The insufficient part 
was extracted from great saphenous vein (GSV) located 
in saphenofemoral junction (SFJ) where USG showed 
incompetent valves and massive venous reflux. Tissues 
after extraction were transported in dry ice and further 
processed in the laboratory.
METhODS
Total antioxidant power measurement. Ferric ion 
reducing ability of plasma (FRAP) was used to deter-
mine total antioxidant power according to the method 
of Benzie et al. (1996). FRAP values were obtained by 
measuring ferric to ferrous ion reduction at low pH (0.3 
M acetate buffer, pH 3.6) coupled with tripyridyltriazine 
oxidation, whose absorbance was measured at 593 nm. 
Tissues were minced in four volumes of 0.05 M phos-
phate buffer, pH 7.8, using Ultra Turrax T25 basic ul-
traspeed tissue grinder (8 × 5 s bursts). All procedures 
were performed on ice. The homogenates were centri-
fuged at 1 000 × g for 15 min (0–4 °C). The resultant su-
pernatant was drawn and the pellet was discarded.
Aliquote of 0.1 ml of each sample was mixed with 
3 ml of reagent mixture (25 ml of acetate buffer (300 
mM, pH 3.6), 0.25 ml 2,4,6-Tris(2-pyridyl)-s-triazine (5 
mM TPTZ) in 40 mM HCl, and 0.25 ml ferric solution 
(20 mM FeCl3) in distilled water). The reagent mixture 
was always freshly prepared. FRAP value was calculated 
by preparing an aqueous solutions of known FeII con-
centration, in the range of 0–1 000 μM (FeSO4 ∙ 7H2O). 
The blank contained FRAP reagent mixture. Reactions 
were performed for 5 min at 37 °C. FRAP values were 
expressed in mmol per milligram of protein.
Enzymatic antioxidant investigation. SOD activ-
ity was measured by the method of Spitz and Oberley, 
(1989). Homogenates of veins were used. The catalytic 
conversion of xanthine to uric acid and O2
•– by xanthine 
oxidase provides an initial constant flux of superoxide 
in a PBS (phosphate-buffered saline) at room tempera-
ture. NBT reduction by O2
•– to the blue formazan was 
followed at 560 nm in a Marcel Media (Poland) spectro-
photometer at room temp. The rate of NBT (Nitroblue 
tetrazolium) reduction in the absence of tissue was used 
as the reference rate (0.020 ± 0.005 absorbance/min). 
When increasing amounts of protein (containing SOD 
activity) were added to the system, the rate of NBT re-
duction was progressively inhibited. The degree of in-
hibition was defined as the percentage of the reference 
rate of NBT reduction when SOD activity was not pres-
ent. The data were plotted as percentage inhibition vs 
protein concentration. One unit of activity was defined 
as the amount of protein causing 50 % inhibition. The 
assay mixture also contained catalase to remove H2O2 
and diethylenetriaminepentaacetic acid (DETAPAC) to 
chelate metal ions capable of redox cycling and inter-
fering with the assay system. The measurements were 
performed spectrophotometrically using a Marcel Media 
spectrophotometer.
Aliquote of 0.1 ml of each supernatant was mixed 
with 0.8 ml of reagent mixture containing: bovine se-
rum albumin (BSA) and DETAPAC in 50 mM potas-
sium phosphate buffer, pH 7.8, 1 mM DETAPAC, 0.13 
mg/ml BSA (12.90 ml), 1.0 U bovine liver catalase (0.5 
ml), 56 µM nitroblue tetrazolium (NBT) (0.5 ml), 0.1 
mM xanthine (1.7 ml), 0.05 M potassium phosphate bu-
ffer (0.3 ml), 50 µM bathocuproine disulfonate disodium 
Table 1. Characteristic of patients (n = 31) with varicose veins 
participating in the study.
 
Mean  ±  S.D. Min Max
Age (years) 50 ± 13 23 68
RBCs × 106/μL 4.6 ± 0.3   4.0 5.2
Hb g/dcL 13.7 ± 0.8 11.8 15.6
Hct  % 41.3 ± 2.3 34.5 45.2
PLTs ×103/μL 238 ± 58 132.0 371.0
WBCs × 103/μL 6.4 ± 2.0 3.6 14.3
HDL mM 1.1 ± 0.3 0.6 1.7
Chol mM 5.5 ± 1.1 4.0 7.8
TG mM 2.8 ± 1.5 0.6 5.0
LDL mM 4.0 ± 1.0 2.0 5.8
Glu mM 5.4 ± 1.3 4.4 10.9
PT  % 93.8 ± 14.4 71.5 132.0
INR 1.0 ± 0.1 0.9 1.5
APTT s 29.8 ± 3.2 22.6 35.5
Fibr g/L 3.5 ± 0.9 2.4 6.2
APTT — activated partial thromboplastin time; Chol — cholesterol; Fibr 
— fibrinogen; Glu — glucose; Hb — hemoglobin; Hct — hematocrit; 
HDL — high-density lipoprotein; INR — international normalized ratio; 
LDL — low-density lipoprotein; PLTs — platelets count; PT — pro-
thrombin time; RBCs — red blood cells count; TG — triglyceride; WBCs 
— white blood cells count; .
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(BCS) salt (0.1 ml) and 0.1 ml of xanthine oxidase (13.2 
U/ml) to achieve the required reference rate.  The re-
agent mixture was always freshly prepared.
All data were expressed in units of SOD activity per 
milligram of protein.
Determination  of lipid peroxidation. Oxidative 
stress and lipid peroxidation have been implicated as 
important mechanisms for chemical-induced cell in-
jury/death and the development of numerous diseases. 
Malondialdehyde (MDA) is a product of lipid peroxida-
tion that appears to be produced in relatively constant 
proportion from the breakdown of polyunsaturated fatty 
acids. MDA was quantified according to the method 
of Buege and Aust (1978) based on thiobarbituric acid 
(TBA) reactivity. The sufficient, insufficient and varicose 
vein homogenates were used in the study and quantifica-
tion of MDA was done by reaction with TBA and meas-
urement of the pink chromophore produced. 
An aliquote of 0.5 ml of each sample was mixed with 
1 ml of reagent mixture prepared by diluting the stock 
solution containing: 30 g trichloroacetic acid (15 % final), 
4.16 ml concentrated HCl (0.2 N final), 0.74 g thiobarbi-
turic acid (0.37 % final), H2O to 0.2 liter. The stock solu-
tion (TCA/HCl/TBA) was heated to 70 °C and stored 
one month in 4 °C. Before use (TCA/HCl/TBA) was 
dissolved in water four times to yield a working solution. 
Butylated hydroxytoluene (BHT) in ethanol was added 
to a final concentration of 0.03 %. Working solution was 
prepared daily and continually stirred with a magnetic 
stir bar. After shaking, the tube was placed into a boil-
ing water bath for 15 min. After cooling in cold water, 
the resulting chromogen was extracted with 3 ml of n-
butyl alcohol by shaking vigorously for 1 min. Separation 
of the organic phase was facilitated by centrifugation at 
1000 × g for 10 min. The TBA-MDA adduct was quanti-
fied using fluorescence emission at 553 nm with excita-
tion at 532 nm. The concentration of TBA-MDA adduct 
was calculated from a standard curve between 0 and 50 
nmol MDA/sample using 1,1,3,3-tetramethoxypropane 
as the standard. MDA concentrations were expressed in 
nmol/mg protein. The measurements were performed 
using an LS-5 spectrofluorimeter (Perkin-Elmer, USA).
Statistical analysis. Values were expressed as median 
(± 25th)–75th quartile. In the absence of a homogene-
ity of variance, the non-parametric Friedman test for de-
pendent variables was used. 
Statistical analyses were performed with R v. 2.6.2 
(2008) http://www.R.project.org. Graphs were produced 
with Statistica v. 7.0 PL.
RESULTS
When the antioxidant power of vein homogenates was 
qualified the highest value of FRAP was observed for 
sufficient veins (0.147 (± 0.09) — 0.27 U/mg protein) 
and the lowest one for varices (0.05 (± 0.02) — 0.1 U/
mg protein) and insufficient veins (0.08 (± 0.06) — 0.16 
U/mg protein). The differences between those values 
were statistically significant (P < 0.001; Fig. 2). 
The activity of SOD was significantly higher (P < 0.001; 
Fig. 3) in homogenates of varices (68.7 (± 63.9) — 79.5 
U/mg protein) and insufficient veins (63.8 (± 53.4) — 
75.4 U/mg protein) than in homogenates of sufficient 
veins (41.2 (± 36.7) — 43.5 U/mg protein). 
The concentration of MDA was significantly higher 
(P < 0.001; Fig. 4) in homogenates of varices (0.48 (± 0.4) 
— 0.6) and insufficient veins (0.26 (± 0.1) — 0.5) than 
in homogenates of sufficient veins (0.06 (± 0.03) — 0.1). 
Figure 2. Total antioxidant power expressed as FRAP in various 
fragments of GSV in patients with chronic venous diseases 
(S) sufficient veins, (IS) insufficient veins, and (V) varices 
(**p < 0.001; by the ANOVA test). 
Figure 3. SOD activity in fragments of GSV in patients with 
chronic venous diseases
(S) sufficient veins, (IS) insufficient veins, and (V) varices  (**p< 
0.001; by the ANOVA test).
Figure 4. MDA concentrations in various fragments of GSV in 
patients with chronic venous diseases
(S) sufficient veins, (IS) insufficient veins, and (V) varices 
(**p < 0.001; by the ANOVA test). 
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DISCUSSIOn
Varicose veins (VVs) of lower limbs are a common 
vascular insufficiency present in about 20 % of the West-
ern population (Antignani & Caliumi, 2007). Dysfunction 
of vascular endothelium has been reported to be the 
main factor leading to the development of VVs. Fur-
thermore, excessive generation of ROS, depletion of an-
tioxidant defense and oxidative stress development have 
been found to damage endothelial cells (Yasim  et al., 
2008). Under physiological conditions generation of ROS 
is under the control of antioxidant defense enzymes. 
Here, in the cell the balance between superoxide dis-
mutase (SOD) and catalase (CAT) activities seems cru-
cial; these enzymes, together with glutathione peroxidase 
(GPx) convert hydrogen peroxides to water and oxygen 
(Drőge, 2002). 
An imbalance between oxidative stress markers — 
MDA generation and SOD activity results in overpro-
duction of ROS, which in turn may lead to the destruc-
tion of lipid membranes, proteins and other molecules in 
the endothelium.
The increased release of MDA contributes to counter-
balancing the varicose vein relaxation and to increasing 
preload in the varicose via MDA-induced venoconstric-
tion. MDA has also been reported to increase release of 
ROS (Han et al., 2005).
Statistical analysis of the results obtained showed sig-
nificant differences between mean SOD activities in 
varicose veins and insufficient veins on the other hand 
(thigh part of GSV in which USG showed deficiency of 
venous valves with massive blood reflux) and normal 
vein (part of vein extracted from malleolus medialis area 
which showed no pathological changes on USG exami-
nation). Those differences were 30 % and 35 %, respec-
tively.
Similar results were observed by Mahmound et al., 
(2002). They pointed towards increased SOD activity 
in hypoxemic veins in varicose areas, compared to ar-
eas considered a normal during USG examination. This 
activity was almost three times higher than activities re-
ported for competent veins.
This phenomenon can be explained by local hydro-
static hypertension resulting from varicose veins, which 
probably can activate many types of adhesion molecules 
(e.g., selectins, integrins-β1 and β2) and many intercellu-
lar-type adhesion molecules (e.g., ICAM-1 and VCAM-
1) as well as increase their receptor expression. This 
leads to an increased leukocyte migration from varicose 
veins (incompetent part extracted from the GSV). After 
reaching high ICAM-1 and VCAM-1 expression, leuko-
cytes do not revert to their starting location (Peschen 
et al., 1999). Many phenomena connected with ROS 
liberation, increased adhesion and increased expression 
of gp100MEL-14 receptor occur in trapped leukocytes 
(Kishimoto et al., 1989). This leads to an increased mi-
gration of inflammatory cells to damaged tissue. In our 
research we tested one of the products, malondialdehyde 
(MDA), that is formed from cell lipids exposed to ROS. 
We observed statistically significant differences between 
MDA concentration and total antioxidant status (TAS) 
measured as the ferric reducing ability of plasma (FRAP) 
in sufficient, insufficient and varicose veins. The MDA 
concentration was inversely proportional to FRAP. The 
highest MDA concentration (lowest FRAP) was ob-
served in varicose and insufficient veins. 
Similar conclusions were reached by Ellerton and 
Stacey (2003) who measured 8-izoprostane concentra-
tions (also one of lipid peroxidation products) and total 
amount of antioxidants. They found that 8-izoprostane 
level was significantly higher in varicose and insufficient 
veins in comparison to veins that showed no pathologi-
cal changes in USG examination. That fact suggested in-
creased lipid peroxidation in varicose veins.
A high level of reactive oxygen species (ROS) was ob-
served in local varicose areas. This was also confirmed 
by our research and by other authors. Flore et al. (2003) 
found a higher ROS level in blood samples taken from 
lower limbs of patients with varicose veins than in those 
from healthy volunteers.
These results confirm that a patients suffering from 
chronic venous insufficiency are constantly under oxida-
tive stress. Their TAS is lowered and lipid peroxidation 
level (measured as MDA concentration) increased.
Our observations correlate with the ones discussed in 
the literature. Numerous researchers draw attention to a 
key role of inflammation — which is the mechanism re-
sponsible for CVI progression and its symptoms (Nico-
laides, 2005). It was amply demonstrated that activation 
markers in venous endothelium and leukocytes during 
CVI (e.g., Glowiński & Glowiński, 2002; Bergan, 2007). 
Interaction between leukocytes and endothelium (which 
results in toxic metabolites e.g., MDA; Rojas & Phillips, 
1999) is promoted by slow venous flow (Danielsson et 
al., 2003). Mahmound et al. (2002) found strong lipid 
peroxidation (increased MDA concentration) around 
insufficient venous valves (compared to normal non-
inflamed vessels). This phenomenon was also confirmed 
in our research. Also Tryankina et al. (2003) drew atten-
tion to decreased amount of plasma antioxidants and in-
creased lipid peroxidation in patients with varicose veins 
in comparison to healthy individuals. All this shows how 
strongly oxidative stress can decrease defense mecha-
nisms of patients witch CVI (Wlaschek et al., 2005).
Research by James et al. (2003), in which  alantoin and 
uric acid (AUR) concentration were assayed in homoge-
nized vein tissues of ten patients with CVI, documented 
that AUR concentration was five times higher than nor-
mal, indicating high oxidative stress induced by neutro-
phils. It is worth mentioning that FRAP assay in those 
patients did not show any significant differences with the 
controls — unlike our research in which we found sig-
nificantly higher FRAP in normal vessels in comparison 
to varicose/insufficient veins.
In oxidative stress environment — an inflamed tissue 
SOD acts as an antioxidant converting reactive biologi-
cally partially reduced oxygen forms (O2
– and H2O2) into 
inactive compounds. In both varicose vein areas and in-
sufficient veins, SOD activity is higher than in compe-
tent veins. Clinical symptoms and morphological lesions 
are proportional to this SOD efficiency. This also proves 
that ROS take part in varicose vein development.
In the presence of reactive biologically partially re-
duced oxygen forms (O2
– and H2O2), an OH• free radi-
cal is formed, which can react with every biological mol-
ecule being in its direct neighborhood. 
Fe2+ + H2O2 → Fe
3+ + OH− + OH•
Fe3+ + O2
– → Fe2+ + O2
This OH• radical may initiate separation of hydrogen 
atom from polyunsaturated fatty acids (LH) or result in 
peroxidation of lipids of cell membranes, whose oxida-
tive forms are strongly cytotoxic. 
OH• + LH → H2O + L
o
Lo  + LH → LOOo
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LOOo + LH → LOOH + Lo
Lipid hydroperoxides (LOOH) are accumulated, and 
in the presence of free iron ions they can initiate addi-
tional lipid peroxidation. 
Fe2+ + LOOH → Fe3+ + LO o + OH−
LO o + LH → LOH + Lo
CVI is also accompanied by increased lipid peroxida-
tion (high MDA concentration — product of lipid per-
oxidation) and dysfunction of antioxidant defense mech-
anisms. The decreased amounts of antioxidants in patho-
logical veins result in increased risk of ROS-induced cell 
and DNA damage. This damage, once done and not 
repaired, causes tissue remodeling, comprises white mus-
cle cell integrity and, consequently, CVI progression and 
complications.
Assaying chosen pro- and anti-oxidant markers: MDA 
concentration, TAS (FRAP) and SOD activity can be 
useful to help determine the severity of venous lesions 
in CVI patients.
Our research provides novel insights in two differ-
ent, but overlapping areas. First, all parameters we re-
searched: antioxidant enzyme activity, TAS and FRAP 
bring us to a conclusion that the main reason behind 
CVI is antioxidative system dysfunction. Second, we be-
lieve that recognition of the role of oxidative stress in 
the development of chronic diseases implicates clinical 
actions and modification of treatment. Further research 
is needed to discover efficient means of lowering oxida-
tive stress. For a practicing physician, information that 
oxidative stress takes part in varicose vein development 
can have a crucial influence on the therapy he/she ap-
plies. Also simple modification of the patients diet and 
lifestyle can have beneficial effects
COnCLUSIOnS
The course of chronic venous disease progresses with 
intensified oxidative stress in blood plasma and tissues 
of insufficient veins and varices in comparison to veins 
unchanged by inflammatory process. 
Measurement of chosen oxidative and antioxidative 
markers in addition to other commonly used methods 
may be helpful in determining vessel lesions in patients 
with CVD. 
The severity of clinical changes is dependent on the 
efficiency of ROS scavenging, which additionally proves 
the participation of free radicals in the pathogenesis of 
CVD. 
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